North Carolina's Comprehensive Cancer Centers Join American Cancer Society Cancer Action Network to Host Annual Cancer Research Breakfast
Raleigh/Durham, N.C. - More than 120 cancer advocates attended the annual American Cancer Society Cancer Action Network (ACS CAN) Research Breakfast hosted by the directors of the three Comprehensive Cancer Centers of North Carolina (UNC Lineberger, Duke Cancer Institute and the Comprehensive Cancer Center of Wake Forest University). The Research Breakfast celebrated the accomplishments and innovative strides made by cancer researchers in North Carolina, and raised awareness among elected officials about the need to increase cancer research funding at the state and national levels. North Carolina is on the cutting edge of cancer research, and this event provided a unique forum to advance the collaborative work among elected officials with leaders in medical, academic, biotech, pharmaceutical and cancer communities.
The ACS CAN Cancer Research Breakfast featured leaders from the cancer community. North Carolina State Representative Dr. Jim Fulghum discussed cancer’s impact in North Carolina. The directors from UNC Lineberger, Duke Cancer Institute and the Comprehensive Cancer Center of Wake Forest University updated the audience on recent accomplishments of their respective cancer centers. The keynote speaker, Dr. Donald McDonnell, Glaxo-Wellcome professor and chairman of the Department of Pharmacology and Cancer Biology at the Duke University School of Medicine and an American Cancer Society research grant recipient, highlighted his innovative research in exploring the connection between obesity, cholesterol and breast cancer. Ms. Norma Boggs, a cancer patient from Duke Cancer Institute (DCI), shared her personal story about being diagnosed with ovarian cancer and participating in a new clinical trial at DCI. North Carolina ACS CAN State Lead Ambassador, Bob Schechner, conveyed the importance of ACS CAN’s vital work to continue the fight for increased cancer research funding in the legislative arena. He urged attendees to join ACS CAN, so that their voices will be heard.
About ACS CAN: The American Cancer Society Cancer Action Network (ACS CAN), the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society, supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem. ACS CAN works to encourage elected officials and candidates to make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer with the training and tools they need to make their voices heard. For more information, visit acscan.org
Photo Caption: Keynote speaker Dr. Donald McDonnell, Glaxo-Wellcome professor and chairman of the Department of Pharmacology and Cancer Biology at the Duke University School of Medicine and Christine Weason, director of government relations for the American Cancer Society Cancer Action Network, spoke at the North Carolina Cancer Research Breakfast.